A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method

Transfusion

Volumn 50, Issue 11, 2010, Pages 2413-2423

  Balan, Sreekumar ^a   Kale, Vaijayanti P ^a   Limaye, Lalita S ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ANTIGENS; ANTIGENS, CD34; BLOOD PRESERVATION; CANCER VACCINES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CHEMOTAXIS, LEUKOCYTE; CRYOPRESERVATION; DENDRITIC CELLS; FETAL BLOOD; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; RECEPTORS, CCR7;

EID: 78349231579     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02706.x     Document Type: Article

References (45)

1. Fong L, Engleman EG,. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000; 18: 245 -73.
2. Aragoneses-Fenoll L, Corbi AL,. Dendritic cells: still a promising tool for cancer immunotherapy. Clin Transl Oncol 2007; 9: 77 -82.
3. Tuyaerts S, Aerts JL, Corthals J, Neyns B, Heirman C, Breckpot K, Thielemans K, Bonehill A,. Current approaches in dendritic cell generation and future implications for cancer immunotherapy. Cancer Immunol Immunother 2007; 56: 1513 -37.
4. De Gruijl TD, Van Den Eertwegh AJ, Pinedo HM, Scheper RJ,. Whole-cell cancer vaccination: from autologous to allogeneic tumor-and dendritic cell-based vaccines. Cancer Immunol Immunother 2008; 57: 1569 -77.
5. Ferlazzo G, Wesa A, Wei WZ, Galy A,. Dendritic cells generated either from CD34+ progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8+ T cells. J Immunol 1999; 163: 3597 -604.
6. Meierhoff G, Krause SW, Andreesen R,. Comparative analysis of dendritic cells derived from blood monocytes or CD34+ hematopoietic progenitor cells. Immunobiology 1998; 198: 501 -13.
7. Mortarini R, Anichini A, Di Nicola M, Siena S, Bregni M, Belli F, Molla A, Gianni AM, Parmiani G,. Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Res 1997; 57: 5534 -41.
8. Paczesny S, Li YP, Li N, Latger-Cannard V, Marchal L, Ou-Yang JP, Bordigoni P, Stoltz JF, Eljaafari A,. Efficient generation of CD34+ progenitor-derived dendritic cells from G-CSF-mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment. J Leukoc Biol 2007; 81: 957 -67.
9. Siena S, Di Nicola M, Bregni M, Mortarini R, Anichini A, Lombardi L, Ravagnani F, Parmiani G, Gianni AM,. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. Exp Hematol 1995; 23: 1463 -71.
10. Santiago-Schwarz F, Rappa DA, Laky K, Carsons SE,. Stem cell factor augments tumour necrosis factor, granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis. Stem Cells 1995; 13: 186 -97.
11. Saraya K, Reid CD,. Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood. Br J Haematol 1996; 93: 258 -64.
12. Sato K, Nagayama H, Takahashi TA,. Generation of dendritic cells from fresh and frozen cord blood CD34+ cells. Cryobiology 1998; 37: 362 -71.
13. Borras FE, Matthews NC, Patel R, Navarrete C,. Dendritic cells can be successfully generated from CD34+ cord blood cells in the presence of autologous cord blood plasma. Bone Marrow Transplant 2000; 26: 371 -6.
14. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, De Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J,. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 1996; 184: 695 -706.
15. Arrighi JF, Hauser C, Chapuis B, Zubler RH, Kindler V,. Long-term culture of human CD34(+) progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34(-)CD14(-) and a CD34(-)CD14(+) dendritic cell precursor. Blood 1999; 93: 2244 -52.
16. Liu A, Takahashi M, Narita M, Zheng Z, Kanazawa N, Abe T, Nikkuni K, Furukawa T, Toba K, Fuse I, Aizawa Y,. Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment. J Immunol Methods 2002; 261: 49 -63.
17. Bontkes HJ, De Gruijl TD, Schuurhuis GJ, Scheper RJ, Meijer CJ, Hooijberg E,. Expansion of dendritic cell precursors from human CD34 (+) progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome. J Leukoc Biol 2002; 72: 321 -9.
18. Ryu KH, Cho SJ, Jung YJ, Kie JH, Koh SH, Kang HJ, Ahn HS, Shin HY,. In vitro generation of functional dendritic cells from human umbilical cord blood CD34+ cells by a 2-step culture method. Int J Hematol 2004; 80: 281 -6.
19. Montesoro E, Castelli G, Morsilli O, Nisini R, Stafsnes MH, Care A, Peschle C, Chelucci C,. Unilineage monocytopoiesis in hematopoietic progenitor culture: switching cytokine treatment at all Mo developmental stages induces differentiation into dendritic cells. Cell Death Differ 2006; 13: 250 -9.
20. Balan S, Kale VP, Limaye LS,. A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells. Transfusion 2009; 49: 2109 -21.
21. Ballen KK, Kurtzberg J, Lane TA, Lindgren BR, Miller JP, Nagan D, Newman B, Rupp N, Haley NR,. Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks. Biol Blood Marrow Transplant 2004; 10: 269 -75.
22. Hasebe H, Nagayama H, Sato K, Enomoto M, Takeda Y, Takahashi TA, Hasumi K, Eriguchi M,. Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients. Biomed Pharmacother 2000; 54: 291 -8.
23. Neves AR, Ensina LF, Anselmo LB, Leite KR, Buzaid AC, Câmara-Lopes LH, Barbuto JA,. Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunol Immunother 2005; 54: 61 -6.
24. Franzke A,. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 2006; 17: 235 -44.
25. Klangsinsirikul P, Russell NH,. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 2002; 30: 495 -501.
26. Trefzer U, Weingart G, Chen Y, Herberth G, Adrian K, Winter H, Audring H, Guo Y, Sterry W, Walden P,. Hybrid cell vaccination for cancer immune therapy: first clinical trial with metastatic melanoma. Int J Cancer 2000; 85: 618 -26.
27. Marten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Von Ruecker A, Eis-Hbinger AM, Mller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T, Schmidt-Wolf IG,. Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 2003; 14: 483 -94.
28. Montagna D, Maccario R, Montini E, Tonelli R, Lisini D, Pagani S, Comoli P, Moretta A, Assirelli E, Basso S, Vitiello A, Pession A, Locatelli F,. Generation and ex vivo expansion of cytotoxic T lymphocytes directed toward different types of leukemia or myelodysplastic cells using both HLA-matched and partially matched donors. Exp Hematol 2003; 31: 1031 -8.
29. Trefzer U, Herberth G, Wohlan K, Milling A, Thiemann M, Sherev T, Sparbier K, Sterry W, Walden P,. Vaccination with hybrids of tumor and dendritic cells induces tumor-specific T-cell and clinical responses in melanoma stage III and IV patients. Int J Cancer 2004; 110: 730 -40.
30. Trefzer U, Herberth G, Wohlan K, Milling A, Thiemann M, Sharav T, Sparbier K, Sterry W, Walden P,. Tumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results. Vaccine 2005; 23: 2367 -73.
31. Hus I, Rolinski J, Tabarkiewicz J, Wojas K, Bojarska Junak A, Greiner J, Giannopoulos K, Dmoszynska A, Schmitt M,. Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1621 -7.
32. Avigan DE, Vasir B, George DJ, Oh WK, Atkins MB, McDermott DF, Kantoff PW, Figlin RA, Vasconcelles MJ, Xu Y, Kufe D, Bukowski RM,. Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma. J Immunother 2007; 30: 749 -61.
33. Wells JW, Cowled CJ, Darling D, Guinn BA, Farzaneh F, Noble A, Galea-Lauri J,. Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity. Cancer Immunol Immunother 2007; 56: 1861 -73.
34. Zhou J, Weng D, Zhou F, Pan K, Song H, Wang Q, Wang H, Wang H, Li Y, Huang L, Zhang H, Huang W, Xia J,. Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses. Cancer Immunol Immunother 2009; 58: 1587 -97.
35. Brown JA, Boussiotis VA,. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008; 127: 286 -97.
36. Hsu AK, Kerr BM, Jones KL, Lock RB, Hart DN, Rice AM,. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy. Biol Blood Marrow Transplant 2006; 12: 855 -67.
37. Fabre JW,. The allogeneic response and tumor immunity. Nat Med 2001; 7: 649 -52.
38. Zheng Z, Takahashi M, Narita M, Toba K, Liu A, Furukawa T, Koike T, Aizawa Y,. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J Hematother Stem Cell Res 2000; 9: 453 -64.
39. Enmei L, Wenwei T, Helen KW, Liu E, Tu W, Law HK, Lau YL,. Decreased yield, phenotypic expression and function of immature monocyte derived dendritic cells in cord blood. Br J Hematol 2001; 113: 240 -6.
40. Salio M, Dulphy N, Renneson J, Herbert M, McMichael A, Marchant A, Cerundolo V,. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. Int Immunol 2003; 15: 1265 -73.
41. Joshi SS, Vu UE, Lovgren TR, Lorkovic M, Patel W, Todd GL, Kuszynski C, Joshi BJ, Dave HP,. Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. J Hematother Stem Cell Res 2002; 11: 337 -47.
42. Lin P, Lu YR, Zhang J, Wei YQ, Wang XJ, Li SF, Wang Q, Xiong ZJ, Ning QZ, Lei S, Mao YQ, Cheng JQ,. Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice. Cancer Biother Radiopharm 2008; 23: 321 -31.
43. Fujii S, Fujimoto K, Osato M, Matsui K, Takatsuki K, Kawakita M,. Induction of antitumor cytotoxic activity using CD34+ cord blood cell-derived and irradiated tumor cell-primed dendritic cells. Int J Hematol 1998; 68: 169 -82.
44. Guo G, Chen S, Zhang J, Luo L, Yu J, Dong H, Xu H, Su Z, Wu L,. Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood. Vaccine 2005; 23: 5225 -30.
45. Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV, Sanderson S, Dave HP, Joshi SS,. Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. J Neuroimmune Pharmacol 2007; 2: 202 -12.